IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey based specialty generic pharmaceutical company, announced it has submitted its eighth abbreviated new drug applications (ANDAs) to …
Recently, various executives in the healthcare industry have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), bluebird bio Inc (NASDAQ:BLUE), …
IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its seventh abbreviated new drug application (ANDA) …
Roth Capital’s healthcare analyst Scott Henry weighed in on IGI Laboratories, Inc. (NYSE:IG), maintainig a Neutral rating and reducing the price target to $7.
In a research report issued this morning, Roth Capital analyst Scott Henry downgraded shares of Igi Laboratories (NYSE:IG) from Buy to Neutral and reduced his price target …
In a research report today, Oppenheimer analyst Rohit Vanjani reiterated an Outperform rating on Igi Laboratories (NYSE:IG) with a $10 price target, following product acquisition …
In a research report issued yesterday, Roth Capital analyst Scott Henry assigned a Buy rating on Igi Laboratories (NYSE:IG), and increased his price …
